Rocket Lab's Earnings Surge Meets Insider Reality Check as Stock Slides from $132 Peak

Rocket Lab hit record $132.55 after blowout Q1 earnings, then dropped 5.87% on insider share sale and macro headwinds, but still up 69% in past month.

Rocket Lab shares touched a fresh all-time high of $132.55 on Thursday, powered by a blowout first-quarter earnings report, only to slam into reverse the next day as an insider share sale and a toughening macro environment triggered aggressive profit-taking. The whipsaw action left the stock at $124.77 on Friday, down 5.87% for the session, though still up 18.30% for the week and 69.52% over the past month.

The retreat came despite crystal-clear fundamental momentum. Rocket Lab generated $200.35 million in revenue for the first quarter, a 63.4% year-over-year surge that topped consensus estimates of $189.65 million. The net loss narrowed to $0.07 per share, matching analyst forecasts, while management lifted its guidance for the current quarter. The company's order backlog stands at $2.2 billion, underscoring the depth of its pipeline across launch services, space systems, and satellite missions.

But the bullish narrative ran headlong into an insider's decision to cash in. Director Alexander R. Slusky sold 100,000 shares on May 12 at an average price of $118.08, trimming his direct holdings by 18.7%. He retains 434,675 shares, worth more than $51 million at current levels. Moves from the boardroom always draw scrutiny after a parabolic run, and this one was no exception.

Wall Street was nonetheless quick to lift its sights after the earnings release. Needham & Company raised its price target from $95 to $120, keeping a buy rating and citing "operational excellence" and the broadening space-services portfolio. Cantor Fitzgerald increased its target to $96, and Citizens to $95. The average analyst target, however, still sits at $97.19 — well below where the stock is trading, leaving a gap between fundamental estimates and market enthusiasm.

Friday's selling pressure was amplified by broader headwinds. Rising global bond yields and persistent inflation anxiety hit growth names especially hard. In the space sector specifically, the planned initial public offering of SpaceX — set for Nasdaq on June 12, 2026, with a target valuation of $1.75 trillion and a $75 billion raise — introduces a significant capital-flow wildcard that could shift investor attention away from smaller operators.

Trading activity reflected the heightened tension. Volume surged to 22 million shares on Friday, while earlier in the week the stock saw as many as 53 million shares change hands during its peak. Short interest stood at 33.29 million shares, or 6.38% of the float, as of late April — a level that suggests some bears are betting against the rally.

Technically, the equity remains stretched. The relative strength index of 65.2 points to elevated, though not extreme, momentum. The stock trades 55.67% above its 50-day moving average and even further from the 200-day line. A pivot top formed on May 14 already triggered a sell signal. The immediate support sits near $121.80, the Friday low. If that level holds, the pullback can be written off as a healthy consolidation following an explosive uptrend. A break below would force a more serious reckoning between the stock's premium valuation and the company's still-unproven path to sustained profitability.

For now, Rocket Lab's operating story remains compelling — revenue growth accelerating, backlog swelling, guidance rising. The question is whether the market will pay the same price for that story after the insider sale and the sector's shifting currents.